Clinical efficacy of amphotericin B colloidal dispersion against infections caused by aspergillus spp

Chemotherapy

Volumn 45, Issue , 1999, Pages 34-38

  Gurwith, M ^a  

^a ALZA CORPORATION   (United States)

Author keywords

ABCD; Amphocil; Amphotericin B; Aspergillus; Colloidal dispersion; Efficacy

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; ANTIFUNGAL AGENT;

ARTICLE; ASPERGILLOSIS; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; NEPHROTOXICITY; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; CLINICAL TRIALS; FUNGEMIA; HUMANS; TREATMENT OUTCOME;

EID: 0033032841     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000048468     Document Type: Article

References (19)

1. Saral R: Candida and Aspergillus infections in immunocompromised patients: An overview. Rev Infect Dis 1991; 13:487-92.
2. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA: Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukaemia. Ann Intern Med 1984; 100:345-351.
3. Burch PA, Karp JE, Merz WG, Kuhlman JE, Fishman EK: Favorable outcome of invasive aspergillosis in patients with acute leukemia. J Clin Oncol 1987;5: I985-I993.
4. van’t Wout JW, Novakova I, Ver-hagen CAH, Fibbe WE, de Pauw BE, van der Meer JWM: The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. J Infection 1991;22:45-52.
5. Denning DW, Lee JY, Hostetler JS, Pappas P, Kauffman CA, Dewsnup DH, Galgiani JN, Graybill JR, Sugar AM, Catanzaro A, Gallis H, Perfect JR, Dockery B, Dismukes WE, Stevens DA: NIAID Mycoses Study Group Multicenter Trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994;97: 135-144.
6. Stevens DA: Overview of amphotericin B colloidal dispersion (Ampho-cil). J Infect 1994;28(suppl I):45-9.
7. Gates C, Pinney RJ: Amphotericin B and its delivery by liposomal and lipid formulations. J Clin Pharm Therapeut 1993; 18: 147-153.
8. Hanson LH, Stevens DA: Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B choles-teryl sulfate colloidal dispersion. Antimicrob Agents Chemother 1992;36:486-488.
9. Bowden RA, Cays M, Gooley T, Mamelok RD, van Burik JA: Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant. J Infect Dis 1996; 173: 1208-1215.
10. Oppenheim BA, Herbrecht R, Kusne S: The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin Infect Dis 1995;21: 1145-1153.
11. Anaissie EJ, Mattiuzzi GN, Miller CB, Noskin GA, Gurwith MJ, Ma-melok RD, Pietrelli LA: Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion. An-timicrob Ag Chemother 1998;42: 606-611.
12. Armitage P, Berry G: Statistical Methods in Medical Research, ed 2. Oxford, Blackwell Scientific, 1987, p 125.
13. Dupont B: Clinical efficacy of amphotericin B colloidal dispersion (Amphocil) against infections caused by Candida spp. Chemotherapy 1999;45(suppl 1):27-33.
14. Denning DW, Stevens DA: Antifungal and surgical treatment of invasive aspergillosis: Review of 2121 published cases. Rev Infect Dis 1990;12:1147-1201.
15. Denning DW: Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996:23:1-7.
16. White MH, Anaissie EJ, Kusne S, Wingard JR, Hiemenz JW, Cantor A, Gurwith MJ, Du Mond C, Mamelok RD, Bowden RA: Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis. Clin Infect Dis 1997; 24:635-642.
17. Lopez-Berestein G, Bodey GP, Fainstein V, Keating M, Frankel LS, Zeluff B, Gentry L, Mehta K: Treatment of systemic fungal infections with liposomal amphotericin B. Arch Intern Med 1989; 149:2533-2536.
18. Chopra R, Blair S, Strang J, Cervi P, Patterson KG, Goldstone AH: Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. J Antimicrob Chemother 1991;28 (suppl B):93-104.
19. Ringden O, Meunier F, Tollemar J, Ricci P, Tura S, Kuse E, Viviani MA, Gorin NC, Klastersky J, Fe-naux P, Prentice HG, Ksionski G: Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother 1991;28(suppl B):73-82.